Gujarat Themis Biosyn Ltd.

BSE: GUJTHEM506879ISIN INE942C01045

Healthcare
Pharmaceuticals
BSE Healthcare

Share price

₹387.70+10.45 (+2.77%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

Splits and bonuses

9 Aug 2024 · Bonus 1:2

52W high: ₹472.10
52W low: ₹225.75
Off 52W high: -17.88%
1M return: +3.94%
3M return: +8.63%
6M return: +2.40%
1Y return: -15.99%
20D avg volume: 18,477
50 DMA: ₹394.17
200 DMA: ₹357.35

Key ratios Consolidated

Market cap: ₹5,046 Cr
Current price: ₹387.70
52W high / low: ₹472.10 / ₹225.75
Face value: ₹1.00
P/E: 0.00
P/B: —
EPS (TTM): ₹0.00
Book value / share: —
ROE: —
ROCE: —
Operating margin: —
Net margin: —
Debt / equity: —
Net debt: —
Interest cover: —
Dividend yield: 0.17%
Dividend / share (TTM): ₹0.67
Payout: —
Cash conversion cycle: —

Financials

Metric	Q1 FY27
Income statement
	43.79
	0.13
	43.92
	28.76
	7.73
	0.00
	4.72
	1.79
	3.97
	14.46
	15.17
	0.00
	15.17
	4.10
	11.07
	1.02
Key metrics
	20.93
	47.80%
	25.30%

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24
Income statement
	43.79	44.23	43.37	42.35	35.87	37.74	39.52	34.72	38.83	42.01	38.86	39.65
	0.13	0.92	0.42	0.82	0.27	1.35	0.24	0.32	0.52	1.02	1.00	1.00
	43.92	45.15	43.78	43.17	36.15	39.08	39.76	35.03	39.35	43.03	39.86	40.65
	28.76	30.82	26.91	24.40	24.03	23.00	22.36	20.84	21.49	22.08	22.17	23.77
	7.73	10.05	6.62	6.92	6.83	6.85	6.55	6.21	6.16	6.14	6.35	6.76
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—	—
	4.72	3.79	4.76	4.85	3.11	3.14	3.02	3.28	3.20	2.98	2.68	2.50
	1.79	1.91	0.96	0.04	0.04	0.07	0.14	0.08	0.07	0.07	0.08	0.05
	3.97	4.04	3.89	2.96	2.03	1.23	1.56	1.44	1.15	0.92	0.98	0.88
	14.46	17.52	11.48	11.16	12.21	12.33	—	—	—	—	—	—
	15.17	14.34	16.87	18.76	12.12	16.09	17.40	14.19	17.86	20.95	17.69	16.89
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—	—
	15.17	14.34	16.87	18.76	12.12	16.09	17.40	14.19	17.86	20.95	17.69	16.89
	4.10	3.45	4.41	4.50	3.06	4.09	4.43	3.62	4.62	5.06	4.68	4.34
	11.07	10.89	12.46	14.27	9.06	12.00	12.97	10.57	13.24	15.89	13.01	12.54
	1.02	1.00	1.14	1.31	0.83	1.10	1.19	0.97	1.82	2.19	1.79	8.63
Key metrics
	20.93	20.29	21.72	21.76	14.19	17.39	19.10	15.71	19.08	21.94	18.75	17.82
	47.80%	45.90%	50.10%	51.40%	39.60%	46.10%	48.30%	45.20%	49.10%	52.20%	48.30%	44.90%
	25.30%	24.60%	28.70%	33.70%	25.30%	31.80%	32.80%	30.40%	34.10%	37.80%	33.50%	31.60%
	—	3.80%	—	5.50%	—	5.80%	—	—	—	—	—	—
	22.10%	17.20%	9.70%	22.00%	-7.60%	-10.20%	1.70%	-12.40%	—	—	—	—
	22.20%	-9.20%	-3.90%	35.00%	-31.60%	-24.50%	-0.30%	-15.70%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22
Income statement
	173.74	165.82	150.80	169.82	148.97	114.85
	2.29	2.43	2.43	4.37	6.02	4.05
	176.02	168.25	153.23	174.19	155.00	118.90
	110.89	106.16	87.69	94.85	77.53	59.87
	31.32	30.43	25.78	25.67	29.73	21.75
	0.00	0.00	0.00	—	—	—
	18.12	16.51	12.64	10.21	7.75	7.08
	4.70	2.95	0.36	0.23	0.20	0.83
	14.86	12.92	5.37	3.54	2.58	2.23
	54.62	52.38	44.81	—	—	—
	65.14	62.09	65.54	79.33	77.47	59.03
	0.00	0.00	0.00	—	—	—
	65.14	62.09	65.54	79.33	77.47	59.03
	16.46	15.41	16.77	20.17	19.50	15.41
	48.69	46.68	48.77	59.16	57.97	43.62
	4.47	4.28	4.48	8.14	39.90	30.03
Key metrics
	84.70	77.96	71.27	83.10	80.25	62.09
	48.75%	47.00%	47.30%	48.90%	53.90%	54.10%
	28.02%	28.20%	32.30%	34.80%	38.90%	38.00%
	—	15.30%	23.50%	—	—	—
	17.51%	10.00%	-11.20%	14.00%	29.70%	—
	9.17%	-4.30%	-17.60%	2.10%	32.90%	—
	—	-123.75	-25.12	—	—	—
	—	1.04	1.87	—	—	—
	—	0.56	0.12	—	—	—
	—	156.74	18.20	—	—	—
	—	87.3	52.3	—	—	—
Balance sheet
	—	503.43	301.31	—	—	—
	—	88.78	51.97	—	—	—
	—	3.12	11.69	—	—	—
	—	60.92	31.24	—	—	—
	—	15.42	5.05	—	—	—
	—	6.02	2.14	—	—	—
	—	286.92	40.58	—	—	—
	—	36.65	14.65	—	—	—
	—	79.16	20.56	—	—	—
	—	159.86	29.89	—	—	—
	—	31.80	0.25	—	—	—
	—	128.06	29.64	—	—	—
	—	287.76	248.38	—	—	—
Cash flow
	—	48.78	91.03	—	—	—
	—	-172.28	-111.82	—	—	—
	—	114.93	26.01	—	—	—
	—	172.53	116.15	—	—	—

Compounded growth

Standalone

Sales CAGR 3Y: +3.64%
Sales CAGR 5Y: —
Profit CAGR 3Y: -6.97%
Profit CAGR 5Y: —
Sales YoY (TTM): +17.51%
Profit YoY (TTM): +9.17%

Consolidated

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 59.34%

Quarter	September 2026	June 2026
Promoter %	59.34%	59.34%

Holder	Type	Holding	Previous	Change
PHARMACEUTICAL BUSINESS GROUP [INDIA] LTD	Promoter Group	38.97%	38.97%	0.00%
THEMIS MEDICARE LIMITED	Promoter Group	17.50%	17.50%	0.00%
QUANT MUTUAL FUND - QUANT MANUFACTURING FUND	Public	7.47%	—	—
AYUSHMAT LTD	Public	2.55%	2.78%	-0.23%
SACHIN DINESH PATEL	Promoter	2.32%	2.32%	0.00%
KOTAK MAHINDRA LIFE INSURANCE COMPANY LTD	Public	2.17%	2.17%	0.00%
BANK OF INDIA FLEXI CAP FUND	Public	1.63%	—	—
Dinesh Shantilal Patel, Jayshree Dinesh Patel, Sachin Dinesh Patel (Trustees of Vividhmargi Trust)	Promoter	0.51%	—	—
NYSHA RUPEN CHOKSI	Promoter	0.02%	0.02%	0.00%
ANAY RUPEN CHOKSI	Promoter	0.02%	0.02%	0.00%
REENA S PATEL	Promoter	0.00%	0.00%	0.00%
JAYSHREE D PATEL	Promoter	0.00%	0.00%	0.00%
DINESH SHANTILAL PATEL	Promoter	0.00%	0.00%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Sun Pharmaceutical Industries Ltd.	4,26,112	1,776.00	38.78	17.90%	+12.13% TTM	+4.79% TTM	+4.92%
Divi's Laboratories Ltd.	2,66,424	10,036.00	91.09	19.00%	+16.35% TTM	+26.84% TTM	+47.61%
Torrent Pharmaceuticals Ltd.	1,79,908	4,730.00	85.71	9.10%	+42.06% TTM	-1.92% TTM	+32.24%
Laurus Labs Limited	1,24,601	2,306.10	93.53	19.70%	+23.03% TTM	+95.38% TTM	+134.59%
Zydus Lifesciences Limited	1,18,703	1,190.00	25.85	19.20%	+21.11% TTM	-2.51% TTM	+22.32%
Dr. Reddy's Laboratories Ltd.	1,14,513	1,372.00	41.50	13.90%	-3.53% TTM	-51.90% TTM	+14.26%
Cipla Ltd.	1,13,110	1,400.10	39.63	14.90%	-0.74% TTM	-47.48% TTM	-6.88%
Mankind Pharma Limited	1,04,631	2,533.15	46.22	13.70%	+13.27% TTM	+27.60% TTM	+6.91%
Aurobindo Pharma Ltd.	97,878	1,701.10	26.38	13.60%	+9.09% TTM	+9.48% TTM	+47.79%
Lupin Ltd	92,145	2,015.00	17.65	28.40%	+24.22% TTM	+20.10% TTM	+0.84%
Glenmark Pharmaceuticals ltd	70,608	2,501.85	39.27	16.20%	+32.94% TTM	+138.48% TTM	+35.48%
Alkem Laboratories Limited	62,054	5,190.00	28.15	18.80%	+13.36% TTM	-5.52% TTM	-8.38%
Abbott India Ltd. S	57,685	27,146.85	35.73	41.90%	+6.29% TTM	+11.18% TTM	-7.56%
Biocon Ltd.	56,061	344.00	134.63	2.90%	+5.70% TTM	-55.37% TTM	-9.53%
Gland Pharma Limited	52,105	3,157.70	46.16	13.70%	+17.57% TTM	+46.55% TTM	+65.09%
Ipca Laboratories Ltd.	50,051	1,973.15	36.40	16.40%	+10.59% TTM	+67.91% TTM	+52.33%
GlaxoSmithkline Pharmaceuticals Ltd.	42,904	2,532.60	37.42	55.40%	+12.12% TTM	+20.03% TTM	-4.84%
Ajanta Pharma Ltd.	41,406	3,313.55	32.79	29.40%	+25.01% TTM	+29.70% TTM	+26.89%
Emcure Pharmaceuticals Limited	41,254	2,174.55	37.75	25.10%	+21.12% TTM	+33.34% TTM	+64.07%
J.B. Chemicals & Pharmaceuticals Lt	38,731	2,412.25	47.77	21.90%	+5.87% TTM	+7.56% TTM	+45.79%
Sai Life Sciences Limited	32,855	1,546.30	90.80	18.10%	—	—	+67.49%
PIRAMAL PHARMA LIMITED	31,659	237.80	-151.21	0.80%	+9.43% TTM	-781.93% TTM	+18.60%
ACUTAAS CHEMICALS LIMITED	30,928	3,777.65	70.51	27.70%	+45.18% TTM	+95.78% TTM	+106.30%
Wockhardt Ltd	30,869	1,899.80	76.22	6.40%	+25.70% TTM	+894.12% TTM	+39.18%
RUBICON RESEARCH LIMITED	28,416	1,716.55	98.59	24.30%	—	—	+164.06%
Gujarat Themis Biosyn Ltd. S	5,046	387.70	103.66	15.30%	+17.51% TTM	+9.17% TTM	-15.99%

Filings & corporate actions

Recent announcements

Please refer to the attachment4 Nov 2026 · Company Update / General
Intimation of re-schedule of Investor & Analyst Meet.2 Nov 2026 · Company Update / Analyst / Investor Meet
The Board Meeting to be held on 04/11/2026 has been revised to 14/11/2026 The Board Meeting to be held on 04/11/2026 has been revised to 14/11/20262 Nov 2026 · Company Update / Board Meeting Rescheduled
Please refer to our Intimation of Investor & Analyst Meet scheduled on 5th November, 202627 Oct 2026 · Company Update / Analyst / Investor Meet
Gujarat Themis Biosyn Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve un-audited standalone ....27 Oct 2026 · Board Meeting / Board Meeting
Kindly refer to the RTA compliance Certificate for the quarter ended 30.09.2026.12 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please refer to our Scrutinizer Report and Voting Results of 45th Annual General Meeting counter signed by the Chairman.1 Oct 2026 · AGM/EGM / AGM
Please refer to our counter signed Scrutinizer''s Report of 45th Annual General Meeting.1 Oct 2026 · AGM/EGM / AGM
Kindly refer to the attachment.30 Sep 2026 · AGM/EGM / AGM
Please refer to our revised outcome of the Annual General Meeting due to typographical error.30 Sep 2026 · AGM/EGM / AGM
Please refer to the Intimation of amendment to Articles of Association of the Company.30 Sep 2026 · Company Update / Amendments to Memorandum & Articles of Association
Please refer to the outcome of 45th Annual General Meeting held on 30.09.202630 Sep 2026 · AGM/EGM / AGM
Kindly refer to the intimation of trading window closure.23 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Please refer to the Newspaper Publication of Corrigendum to the Notice of 45th Annual General Meeting.23 Sep 2026 · Company Update / Newspaper Publication
Please refer to the attachment.21 Sep 2026 · AGM/EGM / AGM
Kindly refer to the attachment.18 Sep 2026 · Corp. Action / Record Date
Please refer to the attachment.18 Sep 2026 · Company Update / Acquisition
Please refer to the Disclosure under Reg 30 of LODR.16 Sep 2026 · Company Update / Allotment of Equity Shares
Please refer to the Outcome of the Board meeting held on 10.09.202610 Sep 2026 · Board Meeting / Outcome of Board Meeting
Please refer to the attachment8 Sep 2026 · AGM/EGM / AGM
Gujarat Themis Biosyn Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/09/2026 ,inter alia, to consider and approve raising funds through ....7 Sep 2026 · Board Meeting / Board Meeting
Please refer to newspaper publication of 45th AGM notice .7 Sep 2026 · Company Update / Newspaper Publication
Please refer to attached BRSR for F.Y. 2025-264 Sep 2026 · Others / Business Responsibility and Sustainability Reporting (BRSR)
Please refer to our Annual Report for F.Y. 2025-264 Sep 2026 · Others / Reg. 34 (1) Annual Report
Please refer to the Notice of 45th Annual General Meeting scheduled on 30.09.20264 Sep 2026 · AGM/EGM / AGM
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pharmaceutical Business Group India Ltd & Others2 Sep 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Kindly refer to the outcome of the Board Meeting held on 01-09-20261 Sep 2026 · Board Meeting / Outcome of Board Meeting
Outcome of the Fund Raising Committee held on 28.08.2026 for allotment of equity shares through QIP28 Aug 2026 · Company Update / Allotment of Equity Shares
Outcome of Fund Raising Committee for QIP Issue Close28 Aug 2026 · Company Update / Qualified Institutional Placement
Gujarat Themis Biosyn Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/09/2026 ,inter alia, to consider and approve Please refer to the intimation ....27 Aug 2026 · Board Meeting / Board Meeting
Please refer to the attachment25 Aug 2026 · Others / Outcome without intimation
Please refer to our Announcement under Reg 30 (LODR) - Updates (Audited Financial Statements - F.Y. 2025-26)25 Aug 2026 · Company Update / General
Please refer to the attachment.23 Aug 2026 · Company Update / Amendments to Memorandum & Articles of Association
Please refer to the attachment.23 Aug 2026 · Company Update / Amendments to Memorandum & Articles of Association
Please refer to the attachment.22 Aug 2026 · AGM/EGM / Postal Ballot
Please refer to the attachment.22 Aug 2026 · AGM/EGM / Postal Ballot
Please refer to the attachment22 Aug 2026 · AGM/EGM / EGM
Please refer to the outcome / proceedings of EGM held on 22.08.202622 Aug 2026 · AGM/EGM / EGM
Earnings Call Transcript14 Aug 2026 · Company Update / Earnings Call Transcript
Please refer to our submission of Call Recordings of the investor/analyst Conference Call held on Monday, August 10, 2026 (IST).10 Aug 2026 · Company Update / Analyst / Investor Meet

Corporate actions

Purpose	Ex date	Record date	Payment date
Final Dividend - Rs. - 0.6700	23 Sep 2026	23 Sep 2026	—
Final Dividend - Rs. - 0.6700	4 Sep 2025	5 Sep 2025	—
Bonus issue 1:2	9 Aug 2024	9 Aug 2024	—
Final Dividend - Rs. - 0.2500	15 Jul 2024	—	—

Board meetings

14 Nov 2026 Board Meeting - Financial Results
4 Nov 2026 Board Meeting - Financial Results
7 Aug 2026 Board Meeting - Financial Results